Asia Rates: An update on our trade ideas


Across EM / Asia, containing the ongoing Delta variant has proven to be more challenging due to relatively low vaccination rates.
Duncan Tan, Eugene Leow02 Aug 2021
  • We are holding on to our strategy to stay paid in 2Y THB NDIRS and 5Y MYR IRS
  • Malaysia’s quickened vaccinations will help contain virus situation and rebuild hike expectations
  • We have hit stop-loss on our Pay 2Y CNY NDIRS idea
  • Markets perceived a shift in PBOC's stance towards possibly more easing in 2H
  • The trajectory of CNY rates is biased lower
Photo credit: AFP Photo


Maintain – Pay 2Y THB NDIRS (entry 0.475%, current 0.405%); Pay 5Y MYR IRS (entry 2.64%, current 2.55%)

Our pay 2Y THB NDIRS and pay 5Y MYR IRS ideas have underperformed. The more challenging COVID-19 circumstances in Malaysia and Thailand have suppressed rate hike expectations and weighed on their swap rates. Across EM / Asia, containing the ongoing Delta variant has proven to be more challenging due to relatively low vaccination rates. Market participants expect monetary policy to stay loose for longer.

At present, new infection rates in both countries are climbing without a peak in sight. However, further downside in THB and MYR 1-5Y swap rates are limited because of depressed levels (not pricing in any rate hikes over the next 12 months). Negative carry on our paid swap ideas are not too punitive (~1-3bps per month). Therefore, we opt to stay paid and hold out for an eventual containment of the virus.

We expect Malaysia to be quicker than Thailand in containing the virus, and by extension, faster at rebuilding rate hike expectations. Malaysia has stepped up daily vaccination rates from ~75,000 doses at end-May to the current ~500,000 doses. At the current pace, Malaysia is likely to fully vaccinate 70-80% of its population by year-end.



Besides vaccinations, fiscal/debt-related developments in Malaysia could be another trigger for 5Y MYR IRS rates to rebound. Malaysia is one of the few bond markets where we project an increase in gross MGS/MGII issuance to MYR179bn in 2021 vs MYR152bn in 2020. Finance Minister Tengku Datuk Seri Zafrul Aziz recently hinted at a possible increase in the statutory debt limit of 60% of GDP to accommodate wider fiscal deficits and higher bond supply to support the economic recovery.

The main risk to our pay THB and MYR swaps strategy is rate cuts by the Bank of Thailand or Bank Negara Malaysia. We presently assess this possibility as low. Policy measures to support the economy in 2H are likely to come mainly from the fiscal front, not so much on the monetary front.

Hit stop-loss on Pay 2Y CNY NDIRS (entry 2.523%, stop-loss 2.35%)

On 29 July, we were stopped out of our pay 2Y CNY NDIRS idea. The idea was initiated on 7 July, in anticipation of higher bond issuances and as a result, tighter interbank liquidity and higher funding rates in 2H.

Shortly after we released our report, PBOC announced a broad-based 0.5% RRR cut on 9 July (effective 15 July). Since then, CNY IRS and CGB yields have eased ~20-25bps across the curve amidst strong downside momentum. Fundamentally, the markets perceived a shift in the PBOC’s stance from tighter liquidity worries in 1H to possibly more easing in 2H.

The near-term liquidity outlook looks quite favourable. PBOC rolled over CNY100bn of the CNY400bn of MLF that matured in July, meaning that net liquidity injection from the RRR cut could be as high as CNY700bn. While Chinese equities stay weak and there is a significant uncertainty overhang, PBOC could continue to net inject small amounts of liquidity via OMOs to support risk sentiments and pre-empt liquidity shortfalls.



Therefore, over the coming 1-3 months, the trajectory of CNY rates is likely to be biased lower. Any bounce in CNY rates, possibly due to transient liquidity tightness, is likely to be capped and subsequently reverse.

Now that we have been stopped out of our pay 2Y NDIRS idea, our exposure to CNY rates has shifted to an outright long duration via our long 30Y CGB idea.



Report Links - 23-Mar-21 30-Mar-21 03-May-21 06-May-21 19-May-21 18-Jun-21
7-Jul-21


To read the full report, click here to Download the PDF.

Duncan Tan

FX and Rates Strategist - Asean
[email protected]

Eugene Leow

Rates Strategist - G3 & Asia
[email protected]


Subscribe here to receive our economics & macro strategy materials.
To unsubscribe, please click here.

The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation.  Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies.  The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation.  The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation. 

This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd and/or DBSVS, may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at [email protected] for matters arising from, or in connection with the report.

DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-878-9999. Company Registration No. 196800306E. 

DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability.  18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.

DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability.  11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.